| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.8 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.9 |
| mRNA | QS11 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.9 |
| mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |